• Explore /
  • Poster
  • / HANNA: Real-world outcomes from an observational study with nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck in Germany.

HANNA: Real-world outcomes from an observational study with nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck in Germany.

Abstract Video & Slides Poster

Authors

Andreas Dietz

Andreas Dietz

Universitaetsklinikum Leipzig, Leipzig, Germany

Andreas Dietz , Manfred Welslau , Dennis Hahn , Christine Langer , Ulrike Bockmühl , Harald Müller-Huesmann , Chia-Jung Busch , Jorge Riera-Knorrenschild , Jens Büntzel , Boris Kubuschok , Jens von der Grün , Thomas Christoph Gauler , Daniela Waldenberger , Eyck von der Heyde

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Advanced/Metastatic Disease

Clinical Trial Registration Number

NCT03114163

Citation

J Clin Oncol 38: 2020 (suppl; abstr 6532)

DOI

10.1200/JCO.2020.38.15_suppl.6532

Abstract #

6532

Poster Bd #

193

Abstract Disclosures

Similar Posters

First Author: Nabil F. Saba

First Author: Maura L. Gillison

First Author: Robert L. Ferris

First Author: Shun Yamamoto